FDA Approvals, News & UpdatesThyroid Cancer
In September 2021, the FDA approved Cabometyx (cabozantinib) for the treatment of patients aged 12 years or older with locally advanced or metastatic thyroid cancer that progressed after VEGFR-targeted therapy who cannot use, or whose disease is not responding to, radioactive iodine therapy.
SurvivorshipThyroid CancerSupport Services
Audrey Guth, 2-Time Cancer Survivor, Dedicates Her Life to Helping Mothers Undergoing Cancer Treatment
By Kelsey Moroz
Audrey Guth is a 2-time cancer survivor, of thyroid cancer and breast cancer. In 2009 she launched the Nanny Angel Network to help children of mothers with cancer go to the camp of their choosing and give their moms a break.
Patient StoriesThyroid Cancer
By Julie Salman
Julie Salman chronicles her experience with thyroid cancer, including dealing with a new reality and coping with radiation.
Although most thyroid cancers can be cured at early stages, it is the most rapidly increasing cancer type in the United States, according to the American Cancer Society. It is not yet clear why the incidence of thyroid cancer is increasing so fast.
Results 1 - 6 of 6